Literature DB >> 22045877

Rare lung disease research: strategies for improving identification and recruitment of research participants.

Samir Gupta1, Ahmed M Bayoumi2, Marie E Faughnan3.   

Abstract

Research in rare lung diseases faces methodologic limitations by virtue of the small number of participants available to be studied. We explored several strategies that may improve researchers' ability to identify and recruit research participants with rare lung diseases. We provide an overview of strategies based on available evidence, previously used approaches, and reasoning. First, disease detection is generally poor and may be improved through strategies targeted at primary care practitioners or directly at patients, thus increasing the pool of patients available for research studies. Next, standardization of case definitions in rare lung diseases is often lacking, hindering research recruitment efforts because of confusion over appropriate recruitment criteria. Expert consensus statements can enhance both clinical care and research recruitment by standardizing definitions. Finally, recruitment strategies using rare lung disease registries, clinical research networks, novel Internet-based direct patient recruitment approaches, and patient organizations may facilitate recruitment of patients with rare lung diseases. In summary, although several strategies for improving the identification and recruitment of research participants with rare lung diseases have been proposed, published examples are few. Objective measurement and reporting of novel recruitment methods and collaboration among researchers facing the same limitations across various rare lung diseases are required. Advancements in this area are vital to the design and performance of much-needed robust clinical studies across the spectrum of rare lung diseases.

Entities:  

Mesh:

Year:  2011        PMID: 22045877     DOI: 10.1378/chest.11-1094

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Variability of oxygenation in possible hepatopulmonary syndrome: effects of requiring two abnormal arterial blood gas results for diagnosis.

Authors:  Samir Gupta; Dhruv Nayyar; Gilles Pomier-Layrargues
Journal:  Dig Dis Sci       Date:  2015-01-14       Impact factor: 3.199

Review 2.  Involving patients in reducing decision uncertainties around orphan and ultra-orphan drugs: a rare opportunity?

Authors:  Devidas Menon; Tania Stafinski; Andrea Dunn; Hilary Short
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

3.  NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights.

Authors:  Ruth Ann Marrie; Gary R Cutter; Robert J Fox; Timothy Vollmer; Tuula Tyry; Amber Salter
Journal:  Int J MS Care       Date:  2021-12-29

Review 4.  Lymphangioleiomyomatosis - a wolf in sheep's clothing.

Authors:  Elizabeth P Henske; Francis X McCormack
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

5.  Brain Vascular Malformation Consortium: Overview, Progress and Future Directions.

Authors:  Amy L Akers; Karen L Ball; Marianne Clancy; Anne M Comi; Marie E Faughnan; Rashmi Gopal-Srivastava; Thomas P Jacobs; Helen Kim; Jeffrey Krischer; Douglas A Marchuk; Charles E McCulloch; Leslie Morrison; Marsha Moses; Claudia S Moy; Ludmilla Pawlikowska; William L Young
Journal:  J Rare Disord       Date:  2013-04-01

Review 6.  Educational aspects of rare and orphan lung diseases.

Authors:  Tiago M Alfaro; Marlies S Wijsenbeek; Pippa Powell; Daiana Stolz; John R Hurst; Michael Kreuter; Catharina C Moor
Journal:  Respir Res       Date:  2021-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.